Stock Symbol:

SVNT

Company Name:

Savient Pharmaceuticals, Inc.

Company Description:

Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States. The KRYSTEXXA is being developed as a treatment for chronic gout in patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. It sells its products directly to drug wholesalers. The company, formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

NASDAQ

Predicted Split Price:

$29.00

Predicted Split Ratio:

3 for 2

5 Day Performance After Split:

3.3%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.